Aclarubicin Plus Cyclophosphamide, Vincristine, and Prednisone (CAOP) in Patients With Previously Untreated Peripheral T-Cell Lymphoma
Shanghai Jiao Tong University School of Medicine
Shanghai Jiao Tong University School of Medicine
Dana-Farber Cancer Institute
National Institutes of Health Clinical Center (CC)
Seagen Inc.
M.D. Anderson Cancer Center
Henan Cancer Hospital
Fondazione Italiana Linfomi - ETS
N.N. Petrov National Medical Research Center of Oncology
Acrotech Biopharma Inc.
UNC Lineberger Comprehensive Cancer Center
Chipscreen Biosciences, Ltd.
Affimed GmbH
New York Medical College
University of Colorado, Denver
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
University of Nebraska
Henan Cancer Hospital
Therapeutic Advances in Childhood Leukemia Consortium
Eastern Cooperative Oncology Group
National Institutes of Health Clinical Center (CC)
Second Affiliated Hospital, School of Medicine, Zhejiang University
The First Affiliated Hospital with Nanjing Medical University
National Institutes of Health Clinical Center (CC)
Czech Lymphoma Study Group
Roswell Park Cancer Institute
Samsung Medical Center
University of California, San Francisco
Eisai Inc.
Acrotech Biopharma Inc.
Zhejiang Cancer Hospital
Chipscreen Biosciences, Ltd.
Peking University
University of Aarhus
Lymphoma Study Association
Southwest Hospital, China
Sun Yat-sen University
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Nanfang Hospital, Southern Medical University
Rutgers, The State University of New Jersey
Case Comprehensive Cancer Center
Yale University
M.D. Anderson Cancer Center
National Cancer Institute (NCI)
Case Comprehensive Cancer Center